Wei Hui
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Department of Rheumatology, Immunology and Hematology, Tibet Autonomous Region People's Hospital, Lhasa 850000, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):923-928. doi: 10.19723/j.issn.1671-167X.2023.05.022.
To investigate the risk factors of different types of Henoch-Schönlein purpura (HSP) in Tibetan patients at high altitude, as to provide reference for correctly identifying high-risk patients.
A retrospective study was used to analyze the 304 HSP patients admitted to Tibet Autonomous Region People's Hospital from April 2014 to March 2022. The gender, age, allergic history, family history, clinical type, laboratory indexes (hemoglobin, platelet count, eosinophil, C-reactive protein (CRP), albumin, immunoglobulin G, immunoglobulin A, complement C3 and C4) were analyzed retrospectively. Univariate and multivariate Logistic regression analysis to screen for risk factors affecting different types of HSP.
Renal HSP patients showed higher IgA [(9.2±1.7) g/L (6.4±2.4) g/L, =0.015], lower complement C3 [(203.3±21.6) mg/dL (301.1±19.5) mg/dL, =0.043], and complement C4 [(33.5±2.3) mg/dL (53.0±7.2) mg/dL, =0.032]. The patients with abdominal HSP showed lower levels of hemoglobin [(119.6±19.6) g/L (146.6±47.3) g/L, =0.038] and plasma albumin [24.8 (22.1, 33.9) g/L 32.6 (24.6, 35.1) g/L, =0.045]. The patients with articular HSP exhibited higher CRP [13.5 (0.2, 20.6) g/L 7.5 (0.1, 15.2) g/L, =0.036] and erythrocyte sedimentation rate (ESR) [24 (5, 40) mm/h 15 (4, 30) mm/h, =0.049]. Elevated IgA and decreased complement C4 were risk factors for renal HSP, anemia and decreased plasma albumin were risk factors for abdominal HSP, and elevated CRP was a risk factor for articular HSP.
The clinical characteristics of different types of HSP in plateau areas were different. Patients with high IgA, low complement C4, anemia, hypoalbuminemia, and significantly elevated CRP should be highly vigilant. Early and effective intervention can improve the clinical efficacy, avoid severe development, and improve the prognosis.
探讨高原地区藏族过敏性紫癜(HSP)患者不同临床类型的危险因素,为正确识别高危患者提供参考。
采用回顾性研究方法,分析2014年4月至2022年3月在西藏自治区人民医院收治的304例HSP患者。对患者的性别、年龄、过敏史、家族史、临床类型、实验室指标(血红蛋白、血小板计数、嗜酸性粒细胞、C反应蛋白(CRP)、白蛋白、免疫球蛋白G、免疫球蛋白A、补体C3和C4)进行回顾性分析。采用单因素和多因素Logistic回归分析筛选影响不同类型HSP的危险因素。
肾型HSP患者的IgA水平较高[(9.2±1.7)g/L 比(6.4±2.4)g/L,P = 0.015],补体C3水平较低[(203.3±21.6)mg/dL 比(301.1±19.5)mg/dL,P = 0.043],补体C4水平较低[(33.5±2.3)mg/dL 比(53.0±7.2)mg/dL,P = 0.032]。腹型HSP患者的血红蛋白水平较低[(119.6±19.6)g/L 比(146.6±47.3)g/L,P = 0.038],血浆白蛋白水平较低[24.8(22.1,33.9)g/L 比32.6(24.6,35.1)g/L,P = 0.045]。关节型HSP患者的CRP水平较高[13.5(0.2,20.6)g/L 比7.5(0.1,15.2)g/L,P = 0.036],红细胞沉降率(ESR)较高[24(5,40)mm/h 比15(4,30)mm/h,P = 0.049]。IgA升高和补体C4降低是肾型HSP的危险因素,贫血和血浆白蛋白降低是腹型HSP的危险因素,CRP升高是关节型HSP的危险因素。
高原地区不同类型HSP的临床特征存在差异。IgA升高、补体C4降低、贫血、低白蛋白血症及CRP显著升高的患者应高度警惕。早期有效干预可提高临床疗效,避免病情进展,改善预后。